HIGHLIGHTS
- who: Timothy J. Craig from the Biomedical Sciences, Penn State University, University Drive, Hershey, PA, USA have published the Article: Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies, in the Journal: (JOURNAL) of 26/Oct/2015
- what: For both studies in this analysis, HAE attack rates during treatment were compared with baseline.
- how: Although these studies were conducted in the United States Canada Europe and Jordan all minorities were from the United States. Similarly the adverse event (AE) data were . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.